Euro-BioImaging is pleased to announce that the first Open Call from the Horizon Europe-funded canSERV project is here! Cancer Researchers are invited to apply for FREE state-of-the-art services and training at several European Research Infrastructures, including Euro-BioImaging ERIC. Within this project, 28 Euro-Bioimaging Nodes offer access to their expertise. It’s an amazing opportunity for the cancer research community to access a wide-ranging portfolio of services.
canSERV invites applications covering the entire range of the oncology developmental pipeline, from supporting discoveries in fundamental research to translational science and personalised oncology, addressing at least one of the four strategic goals of the Cancer Mission:
Understanding of Cancer
Prevention and Early Detection
Diagnosis and treatment
Quality of life for patients and their families
Researchers from academia, industry and SMEs may apply for several service categories including:
disease models,
cutting-edge imaging and structural biology technologies,
biomarker research and development,
new therapeutic solutions,
complex clinical trial design and support,
personalised oncology implementation pipelines and recommendations and
regulatory support and tools to analyse the socioeconomic dimension of research activities.
First CanSERV Open Call
Launch of the first call is today, Thursday, October 12, 2023.
Submission deadline is January 4, 2024 at 14.00 CEST.
The applications will be reviewed by an international, independent review panel and evaluated for scientific excellence, impact and need for the requested services.
The tentative budget for this first call is 1 Mio EURO.
As part of a concerted strategy to tackle the challenges of cancer, the EU-funded project canSERV offers more than 400 innovative cancer research technologies to European and non-European cancer researchers at all levels. The service, or a combination of services and training, can be requested to accelerate ground-breaking discoveries and their translation into clinical applications.
In line with Europe’s Cancer Mission and Beating Cancer Plan, canSERV promotes the development of concrete solutions for cancer by providing a comprehensive set of world-class oncology technologies and state of the art training to cancer scientists.
canSERV Enables Researchers to Cover the Entire Range of the Oncology Developmental Pipeline
More news from Euro-BioImaging
May 19, 2026
Cross-Node Hybrid QuPath Course - Building a distributed European training environment
This spring, imaging experts and trainees from across Europe came together for the 5th edition of the Introductory QuPath Course, a hybrid training event…
Collaborate on the Development of PRISM: Standardized Metadata for Preclinical Imaging Datasets
The FoundingGIDE Preclinical Stream, in collaboration with Euro-BioImaging and international partners, has launched a new survey to support the development of PRISM (PReclinical Imaging…
ACCESS2ACCESS project kicks off to shape the future of transnational access in Europe
Following the official start of the project on 1 May 2026, the ACCESS2ACCESS consortium convened for its kick-off meeting on 12 May, bringing together…